Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography.

IF 12.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Radiology Pub Date : 2025-02-01 DOI:10.1148/radiol.241158
Noam Nissan, Varadan Sevilimedu, Jill Gluskin, Yuki Arita, Delia M Keating, Donna D'Alessio, Hila Fruchtman-Brot, R Elena Ochoa-Albiztegui, Janice S Sung, Maxine S Jochelson
{"title":"Hormonal Regulation of Background Parenchymal Enhancement at Contrast-enhanced Mammography.","authors":"Noam Nissan, Varadan Sevilimedu, Jill Gluskin, Yuki Arita, Delia M Keating, Donna D'Alessio, Hila Fruchtman-Brot, R Elena Ochoa-Albiztegui, Janice S Sung, Maxine S Jochelson","doi":"10.1148/radiol.241158","DOIUrl":null,"url":null,"abstract":"<p><p>Background Background parenchymal enhancement (BPE) is an important diagnostic and prognostic imaging biomarker. Although hormonal regulation of BPE at breast MRI has been investigated, information regarding hormonal regulation of BPE at contrast-enhanced mammography (CEM) remains scarce. Purpose To investigate how BPE at CEM changes across various short- and long-term physiologic and pharmacologic hormonal effects, including menopausal status, lactation, hormone replacement therapy (HRT), and tamoxifen therapy and its cessation. Materials and Methods This retrospective study included CEM examinations performed between December 2012 and January 2024. A computational search was performed to identify CEMs performed in patients with various hormonal statuses and several subgroups of patients were identified, including premenopausal, postmenopausal, lactating, HRT, and tamoxifen subgroups. For patients who received tamoxifen therapy, the first follow-up image at treatment cessation was included, when available. The four ordinal BPE grades, ranging from minimal to marked, as reported in the official radiologic reports were used for analysis. Subgroup comparisons were performed using the Kruskal-Wallis rank sum test and χ<sup>2</sup> test or Fisher exact test. Results A total of 507 female patients (mean age, 49.8 years ± 10.8 [SD]; range, 25-75 years) were included. Premenopausal patients (<i>n</i> = 200) exhibited higher BPE compared with postmenopausal patients (<i>n</i> = 200) (median grade, 1.0 [IQR, 0-2.0] vs 0 [IQR, 0-1.0]; <i>P</i> < .001). Lactating patients (<i>n</i> = 16) exhibited higher BPE (median grade, 3.0; IQR, 2.0-3.0) compared with nonlactating controls (median grade, 1.0; IQR, 0-2.0; <i>P</i> < .001). Patients receiving HRT (<i>n</i> = 14) exhibited higher BPE (median grade, 1.5; IQR, 0-3.0) compared with postmenopausal controls (median grade, 0; IQR, 0-1.0; <i>P</i> < .001). Patients receiving tamoxifen therapy (<i>n</i> = 77) exhibited lower BPE (median grade, 1.0; IQR, 0-2.0) compared with nontreated control patients (9% of patients with high BPE vs 31% for controls, <i>P</i> < .001) and increased BPE (median grade, 2.0; IQR, 1.5-2.5; <i>P</i> = .003) at the cessation of tamoxifen therapy. Conclusion Hormonal effects, including menopausal status, lactation, HRT, and tamoxifen therapy, influenced the degree of BPE at CEM. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Slanetz in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"314 2","pages":"e241158"},"PeriodicalIF":12.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868820/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.241158","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Background Background parenchymal enhancement (BPE) is an important diagnostic and prognostic imaging biomarker. Although hormonal regulation of BPE at breast MRI has been investigated, information regarding hormonal regulation of BPE at contrast-enhanced mammography (CEM) remains scarce. Purpose To investigate how BPE at CEM changes across various short- and long-term physiologic and pharmacologic hormonal effects, including menopausal status, lactation, hormone replacement therapy (HRT), and tamoxifen therapy and its cessation. Materials and Methods This retrospective study included CEM examinations performed between December 2012 and January 2024. A computational search was performed to identify CEMs performed in patients with various hormonal statuses and several subgroups of patients were identified, including premenopausal, postmenopausal, lactating, HRT, and tamoxifen subgroups. For patients who received tamoxifen therapy, the first follow-up image at treatment cessation was included, when available. The four ordinal BPE grades, ranging from minimal to marked, as reported in the official radiologic reports were used for analysis. Subgroup comparisons were performed using the Kruskal-Wallis rank sum test and χ2 test or Fisher exact test. Results A total of 507 female patients (mean age, 49.8 years ± 10.8 [SD]; range, 25-75 years) were included. Premenopausal patients (n = 200) exhibited higher BPE compared with postmenopausal patients (n = 200) (median grade, 1.0 [IQR, 0-2.0] vs 0 [IQR, 0-1.0]; P < .001). Lactating patients (n = 16) exhibited higher BPE (median grade, 3.0; IQR, 2.0-3.0) compared with nonlactating controls (median grade, 1.0; IQR, 0-2.0; P < .001). Patients receiving HRT (n = 14) exhibited higher BPE (median grade, 1.5; IQR, 0-3.0) compared with postmenopausal controls (median grade, 0; IQR, 0-1.0; P < .001). Patients receiving tamoxifen therapy (n = 77) exhibited lower BPE (median grade, 1.0; IQR, 0-2.0) compared with nontreated control patients (9% of patients with high BPE vs 31% for controls, P < .001) and increased BPE (median grade, 2.0; IQR, 1.5-2.5; P = .003) at the cessation of tamoxifen therapy. Conclusion Hormonal effects, including menopausal status, lactation, HRT, and tamoxifen therapy, influenced the degree of BPE at CEM. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Slanetz in this issue.

对比增强乳房x线摄影中背景实质增强的激素调节。
背景实质增强(BPE)是一种重要的诊断和预后成像生物标志物。虽然已经研究了乳腺MRI对BPE的激素调节,但关于对比增强乳房x线摄影(CEM)对BPE的激素调节的信息仍然很少。目的研究CEM时BPE在各种短期和长期生理和药理学激素效应下的变化,包括绝经状态、哺乳期、激素替代治疗(HRT)、他莫昔芬治疗和停药。材料和方法本回顾性研究包括2012年12月至2024年1月期间进行的CEM检查。通过计算搜索来确定在不同激素状态的患者中进行的CEMs,并确定了几个患者亚组,包括绝经前、绝经后、哺乳期、HRT和他莫昔芬亚组。对于接受他莫昔芬治疗的患者,在治疗停止时的第一次随访图像包括在内,如果有的话。官方放射学报告中报告的四个有序BPE等级,从最小到标记,用于分析。亚组比较采用Kruskal-Wallis秩和检验、χ2检验或Fisher精确检验。结果共507例女性患者(平均年龄49.8岁±10.8 [SD];范围:25-75岁)。绝经前患者(n = 200)比绝经后患者(n = 200)表现出更高的BPE(中位分级,1.0 [IQR, 0-2.0] vs 0 [IQR, 0-1.0];P < 0.001)。哺乳期患者(n = 16)表现出更高的BPE(中位等级,3.0;IQR, 2.0-3.0)与非泌乳对照组相比(中位评分,1.0;差,0 - 2.0;P < 0.001)。接受HRT治疗的患者(n = 14)表现出更高的BPE(中位评分,1.5;IQR, 0-3.0)与绝经后对照组相比(中位评分,0;差,0 - 1.0;P < 0.001)。接受他莫昔芬治疗的患者(n = 77)表现出较低的BPE(中位等级,1.0;IQR, 0-2.0)与未治疗的对照组患者(9%的高BPE患者vs 31%的对照组,P < 0.001)和BPE增加(中位分级,2.0;差,1.5 - -2.5;P = 0.003)。结论激素作用,包括绝经状态、哺乳期、HRT和他莫昔芬治疗,影响CEM时BPE的程度。©RSNA, 2025本文可获得补充材料。参见Slanetz在本期的社论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiology
Radiology 医学-核医学
CiteScore
35.20
自引率
3.00%
发文量
596
审稿时长
3.6 months
期刊介绍: Published regularly since 1923 by the Radiological Society of North America (RSNA), Radiology has long been recognized as the authoritative reference for the most current, clinically relevant and highest quality research in the field of radiology. Each month the journal publishes approximately 240 pages of peer-reviewed original research, authoritative reviews, well-balanced commentary on significant articles, and expert opinion on new techniques and technologies. Radiology publishes cutting edge and impactful imaging research articles in radiology and medical imaging in order to help improve human health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信